Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Early Approval of 4 Products Urged by Council
January 30, 2006
- Gaps Remain in Participation of Joint-stock Companies in Medical Services
January 30, 2006
- Outline of FY2006 Medical Fee Revision Approved by Chuikyo
January 30, 2006
- Nichi-iko to Make 108 GE Drugs Available in All Specifications
January 30, 2006
- Original and Generic Drugs "Not Bioequivalent": Prof. Masada
January 30, 2006
- 3 New Procedures to Be Covered by Insurance in April
January 23, 2006
- R&D NEWS IN BRIEF
January 23, 2006
- NEW PRODUCTS
January 23, 2006
- TOPICS 3 articles
January 23, 2006
- JPMA Approves FY2006 Action Plan
January 23, 2006
- Review Process Will Be Speeded Up in 2nd Half of FY2006: PMDA Director Miyajima
January 23, 2006
- SEMINAR
January 23, 2006
- Mr Matsutani of HPB Supports Revised Prescription Form
January 23, 2006
- Eligibility Criteria for DPC Approved: Chuikyo
January 23, 2006
- Korosho Proposes Addition, Not Replacement of Prescription Form
January 23, 2006
- 200 More Hospitals Expected to Participate in DPC
January 23, 2006
- BUSINESS NEWS IN BRIEF
January 23, 2006
- Korosho to Eliminate Med. Institutions for Nursing Care
January 23, 2006
- New Union Opposes Banyu's Restructuring Plan
January 23, 2006
- Premiums Based on % of Referred Patients to Be Abolished
January 23, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…